Back
Madrigal Pharmaceuticals Vs. Akero Therapeutics Industry Stock Comparison
Buy
77
MDGL
Madrigal Pharmaceuticals
Last Price:
279.95
Seasonality Move:
1.42%
Buy
75
AKRO
Akero Therapeutics
Last Price:
23.45
Seasonality Move:
38.97%
Buy
77
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $280.16. The Score for MDGL is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $23.46. The Score for AKRO is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $280.16
The current trend is moderately bullish and MDGL is experiencing slight selling pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $23.46
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.83 | Buy |
| Relative Strength Index (14 RSI): | 60.7 | Buy |
| Chaikin Money Flow: | -376014 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (236.04 - 281.98) | Buy |
| Bollinger Bands (100): | (213.5 - 264.54) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.7 | Buy |
| Relative Strength Index (14 RSI): | 57.52 | Buy |
| Chaikin Money Flow: | 2733533 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.57 - 23.83) | Buy |
| Bollinger Bands (100): | (19.6 - 25.96) | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 278.45 | Buy |
| 20-day SMA: | 266.97 | Buy |
| 50-day SMA: | 237.01 | Buy |
| 200-day SMA: | 212.46 | Buy |
| 8-day EMA: | 278.44 | Buy |
| 20-day EMA: | 267.14 | Buy |
| 50-day EMA: | 250.28 | Buy |
| 200-day EMA: | 226.23 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.04 | Buy |
| 20-day SMA: | 22.45 | Buy |
| 50-day SMA: | 21.05 | Buy |
| 200-day SMA: | 23.46 | Buy |
| 8-day EMA: | 23.21 | Buy |
| 20-day EMA: | 22.53 | Buy |
| 50-day EMA: | 22.01 | Buy |
| 200-day EMA: | 25.3 | Sell |
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.29 per share, an increase next quarter of $1.43 per share, a decrease this year of $8.67 per share, and an increase next year of $10.24 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.83 per share, and a decrease next year of $0.65 per share.
Madrigal Pharmaceuticals Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||